Q2 Earnings Estimate for LRMR Issued By Wedbush
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Wedbush issued their Q2 2026 EPS estimates for shares of Larimar Therapeutics in a research report issued on Wednesday, April 30th. Wedbush analyst L. Chico forecasts that the company will post earnings per share of ($0.41) for the quarter. The consensus estimate for Larimar Therapeutics’ current full-year […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Wedbush issued their Q2 2026 EPS estimates for shares of Larimar Therapeutics in a research report issued on Wednesday, April 30th. Wedbush analyst L. Chico forecasts that the company will post earnings per share of ($0.41) for the quarter. The consensus estimate for Larimar Therapeutics’ current full-year […]
